- Dina Katabi, Ph.D.: World leader in healthcare AI applications at MIT; inventor of groundbreaking wireless devices for passive assessment of symptoms, behavior, and treatment responses in.
Cyclerion Therapeutics, Inc. (NASDAQ:CYCN – Get Free Report) was the recipient of a significant decline in short interest during the month of September. As of September 30th, there was short interest totalling 15,900 shares, a decline of 14.5% from the September 15th total of 18,600 shares. Based on an average daily volume of 8,600 shares, […]
Cyclerion Therapeutics, Inc. (NASDAQ:CYCN – Get Free Report) saw a large growth in short interest in the month of July. As of July 15th, there was short interest totalling 33,600 shares, a growth of 20.0% from the June 30th total of 28,000 shares. Approximately 1.6% of the shares of the company are short sold. Based […]
Cyclerion Therapeutics, Inc. (NASDAQ:CYCN – Free Report)’s stock price rose 0.7% during trading on Tuesday . The stock traded as high as $4.17 and last traded at $4.15. Approximately 6,061 shares were traded during trading, a decline of 60% from the average daily volume of 15,031 shares. The stock had previously closed at $4.12. Cyclerion […]